NKTR · Nektar Therapeutics · Executive Compensation

$39.22 +2.58 (+7.04%) At close · Oct 20

Russell 2000 member Rebalance outlook locked

Market Cap

$1.25B

34.14M

Volume · Oct 20 1.06M Avg daily vol (3M) 1.12M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	President and Chief Executive Officer	$1,106,282	—	$942,081	$2,986,535	$1,106,282	$115,774	$6,256,954
Jonathan Zalevsky	Chief Research and Development Officer	$717,560	—	$271,750	$861,497	$452,000	$17,551	$2,320,358
Mark A. Wilson	Former Chief Legal Officer	$645,950	—	—	—	—	$21,951	$667,901

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	President and Chief Executive Officer	$1,084,590	—	—	$1,596,122	$976,131	$105,850	$3,762,693
Jonathan Zalevsky	Chief Research and Development Officer	$703,490	—	—	$460,420	$431,885	$15,825	$1,611,620
Mark A. Wilson	Chief Legal Officer	$540,000	—	—	$399,030	$336,600	$21,697	$1,297,327
Sandra Gardiner	Interim Chief Financial Officer	—	—	—	—	—	$460,850	$460,850

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	President and Chief Executive Officer	$1,084,590	—	—	$927,160	$1,030,361	$93,465	$3,135,576
Jonathan Zalevsky	Chief Research and Development Officer	$703,490	—	—	$178,300	$400,989	$490,585	$1,773,364
Jillian Thomsen	Former Chief Financial Officer and Chief Accounting Officer	$355,760	—	—	—	—	$883,999	$1,239,759
Mark A. Wilson	Chief Legal Officer	$540,000	—	—	$231,790	$307,800	$20,878	$1,100,468
Sandra Gardiner	Interim Chief Financial Officer	—	—	—	—	—	$376,300	$376,300

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	President and Chief Executive Officer	$1,084,590	—	$4,032,255	$5,409,410	$650,754	$98,821	$11,275,830
Mark A. Wilson	Chief Legal Officer	$527,500	—	$1,629,478	$2,185,994	$194,400	$28,093	$4,565,465
Jillian Thomsen	Former Chief Financial Officer and Chief Accounting Officer	$522,200	—	$1,629,478	$2,185,994	$198,000	$22,645	$4,558,317
Jonathan Zalevsky	Chief Research and Development Officer	$703,490	—	$1,325,673	$1,778,436	$253,256	$289,625	$4,350,480

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Robin	President and Chief Executive Officer	$1,053,000	—	$5,691,794	$3,326,492	$1,000,350	$81,980	$11,153,616
Jonathan Zalevsky	Chief Research and Development Officer	$683,000	—	$2,391,094	$1,397,498	$471,270	$8,385	$4,951,247
Mark A. Wilson	Chief Legal Officer	$500,000	—	$1,707,078	$998,320	$287,500	$10,763	$3,503,661

Executive changes

Person	Role	Change	Effective	Filed
Linda Rubinstein	interim Chief Financial Officer and the principal financial and accounting officer	Appointed	2026-05-15	2026-05-08
Sandra Gardiner	interim Chief Financial Officer	Retired	2026-05-15	2026-05-08
Jillian Thomsen	Chief Financial Officer	Terminated	2023-06-16	2023-06-23
Kevin Brodbeck	SVP of Technical Operations	Resigned	—	2023-04-17
Sandra Gardiner	interim Chief Financial Officer	Appointed	2023-04-17	2023-04-17
Jillian Thomsen	Chief Financial Officer	Resigned	2023-04-17	2023-04-17

Leadership

Howard Robin CEO
Linda Rubinstein CFO
Sandra Gardiner CFO
Jillian Thomsen Chief Accounting Officer
Diana M. Brainard, M.D. Board Member

Key facts CIK 906709 CUSIP 640268306 13F (30d) 14 filings 14 filers Visit website Investor relations